Stockreport

Industry Analysts Just Upgraded Their Esperion Therapeutics, Inc. (NASDAQ:ESPR) Revenue Forecasts By 15% [Yahoo! Finance News]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Esperion Therapeutics, Inc.NASDAQ:ESPRAfter this upgrade, Esperion Therapeutics' ten analysts are now forecasting revenues of US$199m in 2020. This would be a huge 34% i [Read more]